Concepedia

Anna Rogojina

AR

8

Publications

904

Citations

8

H-Index

2003

Active since

Affiliations

University of Florida(Current)

University of Illinois Chicago, Rockford campus

The University of Texas Health Science Center at San Antonio

St. Jude Children's Research Hospital

Florida College

Anna Rogojina is an author at University of Florida specializing in drug discovery, cell biology, and cancer therapeutics.

Top concepts

Publications per year

2003–2023

8

Publications

8

A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity

Sajid Khan, Xuan Zhang, Dongwen Lv et al. · Nature Medicine · 2019 · 608 citations · Full text

, , +7

Topoisomerase Assays

John L. Nitiss, Eroica Soans, Anna Rogojina et al. · Current Protocols in Pharmacology · 2012 · 99 citations · Full text

Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines.

Anna Rogojina, William E. Orr, Bong Keun Song et al. · PubMed · 2003 · 82 citations

Multiplex immunoassay analysis of biomarkers in clinically accessible quantities of human aqueous humor.

Rajesh Sharma, Anna Rogojina, K V Chalam · PubMed · 2009 · 43 citations

Trapped topoisomerase II initiates formation of de novo duplications via the nonhomologous end-joining pathway in yeast

Nicole Stantial, Anna Rogojina, Matthew Gilbertson et al. · Proceedings of the National Academy of Sciences · 2020 · 29 citations · Full text

Rows per page

1–5 of 8